ConductScience.org, home

Paper11462001

Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine.

Guirakhoo F and 11 others. J Virol, 2001. Cited by 184 papers, by iCite.

Cite this record

ConductScience Library. Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine. Papers, record 11462001. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11462001

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine.
PubMed
Journal
J Virol
PubMed
Year
2001
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
184
iCite
Relative citation ratio, by iCite
4.49
iCite
Revised in PubMed
2019-12-10
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Guirakhoo FF
2Arroyo JJ
3Pugachev KVK V
4Miller CC
5Zhang ZXZ X
6Weltzin RR
7Georgakopoulos KK
8Catalan JJ
9Ocran SS
10Soike KK
11Ratterree MM
12Monath TPT P

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DengueMajor topic
Dengue VirusMajor topic
Viral VaccinesMajor topic
Yellow fever virusMajor topic
Animals
Chlorocebus aethiops
Mice
Reassortant Viruses
Vero Cells

Source PubMed

Download CSV of topics

References52

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110074160Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties.J Virol1999https://conductscience.org/library/papers/10074160PubMed
210967284Dengue viral infections; pathogenesis and epidemiology.Microbes Infect2000https://conductscience.org/library/papers/10967284PubMed
37723688Studies on serological cross-reaction in sequential flavivirus infections.Microbiol Immunol1994https://conductscience.org/library/papers/7723688PubMed
45419208Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion.Yale J Biol Med1970https://conductscience.org/library/papers/5419208PubMed
510933719Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response.J Virol2000https://conductscience.org/library/papers/10933719PubMed
610664386
Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins.
Arch Virol1999https://conductscience.org/library/papers/10664386PubMed
76824120Original antigenic sin in dengue.Am J Trop Med Hyg1983https://conductscience.org/library/papers/6824120PubMed
88146129Dengue: the risk to developed and developing countries.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/8146129PubMed
93277268Pathogenesis of dengue: challenges to molecular biology.Science1988https://conductscience.org/library/papers/3277268PubMed
108465377Use of 'original antigenic sin' theory to determine the serotypes of previous dengue infections.Trans R Soc Trop Med Hyg1993https://conductscience.org/library/papers/8465377PubMed
1210364309Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E.J Virol1999https://conductscience.org/library/papers/10364309PubMed
1310217584
Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
Vaccine1999https://conductscience.org/library/papers/10217584PubMed
144984581Immunologic studies with yellow fever and selected African group B arboviruses in rhesus and vervet monkeys.Am J Trop Med Hyg1970https://conductscience.org/library/papers/4984581PubMed
1510233934Dengue virus structural differences that correlate with pathogenesis.J Virol1999https://conductscience.org/library/papers/10233934PubMed
1610030052[Serotypes and genotypes of dengue virus circulating in Venezuela, 1990-1997].Acta Cient Venez1998https://conductscience.org/library/papers/10030052PubMed
179519821Identification of a major determinant of mouse neurovirulence of dengue virus type 2 using stably cloned genomic-length cDNA.J Gen Virol1998https://conductscience.org/library/papers/9519821PubMed
1810608744Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.J Infect Dis2000https://conductscience.org/library/papers/10608744PubMed
192665015Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade.Rev Infect Dis1989https://conductscience.org/library/papers/2665015PubMed
2010329547
Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
Virology1999https://conductscience.org/library/papers/10329547PubMed
218447176Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines.Vaccine1993https://conductscience.org/library/papers/8447176PubMed

See all 52 referencesDownload CSV of references

Cited by91

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 184 citations.

PMIDTitleJournalYearIn PapersSource
42523811Targeting dengue through mucosal vaccination: the potential of NS1 and bacterial spore-based delivery platforms.Front Immunol2026https://conductscience.org/library/papers/42523811PubMed
42356234Effect of Short-Term Grape Powder Supplementation in Patients with Crohn's Disease: A Pilot Study.Nutrients2026https://conductscience.org/library/papers/42356234PubMed
42339734A secretion-deficient DENV1 DNA vaccine induces durable immunity and confers protection against DENV2.Zool Res2026https://conductscience.org/library/papers/42339734PubMed
41917113Integrative immunogenomic strategy for designing a multi-epitope vaccine against Zika and Dengue viruses.Sci Rep2026https://conductscience.org/library/papers/41917113PubMed
41213642Safety and immunogenicity of a tetravalent dengue vaccine (CYD-TDV) in HIV-positive adults aged 18-50 years in Brazil: Results from a phase II, randomized, observer-blind, placebo-controlled trial.Hum Vaccin Immunother2025https://conductscience.org/library/papers/41213642PubMed
40473809T Cell Responses During Dengue Infection.Curr Top Microbiol Immunol2026https://conductscience.org/library/papers/40473809PubMed
40432141Development of New Live-Attenuated Vaccine Candidates Lacking Antibody-Dependent Enhancement (ADE) Against Dengue.Vaccines (Basel)2025https://conductscience.org/library/papers/40432141PubMed
40044132Advancements in dengue vaccines: A historical overview and pro-spects for following next-generation candidates.J Microbiol2025https://conductscience.org/library/papers/40044132PubMed
39861846Latin America's Dengue Outbreak Poses a Global Health Threat.Viruses2025https://conductscience.org/library/papers/39861846PubMed
39861790Animal Models, Therapeutics, and Vaccine Approaches to Emerging and Re-Emerging Flaviviruses.Viruses2024https://conductscience.org/library/papers/39861790PubMed
39700304Genetic diversity of dengue virus circulating in the Philippines (2014-2019) and comparison with dengue vaccine strains.PLoS Negl Trop Dis2024https://conductscience.org/library/papers/39700304PubMed
38543793Single-Dose Immunogenic DNA Vaccines Coding for Live-Attenuated Alpha- and Flaviviruses.Viruses2024https://conductscience.org/library/papers/38543793PubMed
38140260A Novel, Comprehensive A129 Mouse Model for Investigating Dengue Vaccines and Evaluating Pathogenesis.Vaccines (Basel)2023https://conductscience.org/library/papers/38140260PubMed
37331111An in vitro workflow to create and modify infectious clones using replication cycle reaction.Virology2023https://conductscience.org/library/papers/37331111PubMed
35835315A multiple-target mRNA-LNP vaccine induces protective immunity against experimental multi-serotype DENV in mice.Virol Sin2022https://conductscience.org/library/papers/35835315PubMed
35705721A canine-derived chimeric antibody with high neutralizing activity against canine parvovirus-2.AMB Express2022https://conductscience.org/library/papers/35705721PubMed
35608749Dengue Vaccines: An Update.BioDrugs2022https://conductscience.org/library/papers/35608749PubMed
34499320Vaccine-Associated Enhanced Viral Disease: Implications for Viral Vaccine Development.BioDrugs2021https://conductscience.org/library/papers/34499320PubMed
34209433Live Viral Vaccine Neurovirulence Screening: Current and Future Models.Vaccines (Basel)2021https://conductscience.org/library/papers/34209433PubMed
34036241Dengvaxia: the world's first vaccine for prevention of secondary dengue.Ther Adv Vaccines Immunother2021https://conductscience.org/library/papers/34036241PubMed

See all 91 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11462001

GET https://conductscience.org/api/papers/v1/11462001/references?page=2